A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the global population, with prevalence varying by ...

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular ...

In summary, the study shows that fatty liver is very common in people with type 2 diabetes, especially when obesity is also ...

Discover how sugar quietly damages your liver through dangerous mechanisms. Learn about fatty liver disease, inflammation, ...

Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced today ...

Researchers assess the ability of the Risk Estimation of Tumor REcurrence After Transplant score to predict recurrence of hepatocellular carcinoma in patients who underwent liver transplants as a ...

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...